Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

3,288 questions · 3,354 findings · 516 reviews · Headline outcomes only

No studies found 720 · 21.5%GRADE not reported 164 · 4.9%Very low 950 · 28.3%Low 932 · 27.8%Moderate 434 · 12.9%High 154 · 4.6%

Discontinuing cholinesterase inhibitor vs continued cholinesterase inhibitor

Change in NPI · people with dementia
2 findings from 1 review

Ultrasound‐guided injection vs non‐image‐guided injection

Participant‐assessed success 50% improvement on numerical rating 0 to 10 scale for pain) · Patients with shoulder pain

It is very uncertain whether ultrasound‐guided injection changes participant‐assessed success 50% improvement on numerical rating 0… compared with non‐image‐guided injection (very low certainty).

1 finding from 1 review

Peer support vs usual care

Psychological distress Measures: ‐ Parenting Stress Index (PSI‐SF) ‐ Psychiatric Symptom Index (PSI) ‐ PSI anxiety sub‐scale ‐ State anxiety inventory ‐ Center for Epidemological Studies Depression Scale (CES‐D) ‐ Profile of Mood State Inventory (... · parents and carers of children with complex needs
1 finding from 1 review

Surfactant administration via thin catheter (S‐TC) vs surfactant administration through an endotracheal tube (S‐ETT)

Severe intraventricular haemorrhage · preterm infants with or at risk of respiratory distress syndrome

Surfactant administration via thin catheter (S‐TC) may leads to lower severe intraventricular haemorrhage (grade III or IV) compared with surfactant administration through an endotracheal tube (S‐ETT) (low certainty).

1 finding from 1 review

High vs standard volume of fortified human milk or preterm formula

Extrauterine growth restriction at discharge · preterm or low birth weight infants

High showed no clear difference in extrauterine growth restriction at discharge compared with standard volume of fortified human milk or preterm formula (low certainty).

1 finding from 1 review

Cannabinoids vs placebo

Adverse events: psychological disorders · diagnosis of dementia (dementia in Alzheimer’s disease, vascular dementia, or mixed dementia; any severity

Comparison: cannabinoids showed no clear difference in adverse events ‐ psychiatric disorders ‐ total psychiatric disorders ( compared with placebo (low certainty).

1 finding from 1 review